The BARDA investments could go to waste, but ramping up Covid-19 vaccine production will help avoid delivery delays if a vaccine is approved.
Dinorah Delphin has unveiled another magnificent issue of the Immortalists Magazine. She has clearly focused her contributing authors on the world pandemic, with impressive results.
One of the outstanding articles is from our pal, the Chairman of the USTP, Gennady Stolyarov. Gennady levels an eviscerating attack on the American health care system.
I can see that Gennady has a visceral reaction to mass death. There is passionate, broiling anger in the lines of his article. He seems to be mounting a crusade, and I’m going to confess that I’m considering arming myself for battle.
Continue reading “IMMORTALISTS MAGAZINE’s 4th PUBLICATION!” »
Elon Musk has unveiled plans to implant computer chips in people’s brains that the US billionaire says will treat brain diseases and enable superhuman intelligence.
Neuralink, a secretive company set up by Mr Musk two years ago, has said it plans to begin tests of its “brain-computer interface” technology on humans in the next year.
Mr Musk, 48, the chief executive of Tesla and SpaceX, said the technology will help “solve brain disorders of all kinds” and allow humans to merge with artificial intelligence.
Strokes, seizures, loss of smell and taste and other neurological deficits are showing up in patients critically ill with the coronavirus.
Although the virus is classified as a respiratory disorder and primarily damages the lungs, clinicians are seeing patients with a wide array of symptoms, from seizures to hallucinations, brain inflammation, disorientation, delirium and loss of smell and taste.
“I had a patient, a young guy, 48, who attended a party in New Rochelle two weeks before and came in with hallucinations and confusion,” said Dr. Pooia Fattahi, regional chair of neurology for Trinity Health Of New England. The patient had no fever and only a slight cough. Still, aware some COVID-19 patients show up at hospitals with seizures, strokes and confusion, Fattahi suspected, correctly, that the patient had COVID-19. Three of those who attended the same New Rochelle party ultimately died of the virus.
Researchers have found a way to decode neural signals and transform them back into movement and touch sensation for paralyzed patients.
Via Harvard David Sinclair “You may have seen this chart in my last newsletter, but it’s believed a bats’ ability to keep their inflammatory response down is one of the reasons they are able to harbor many types of viruses. Most coronavirus-related deaths in humans are due to the immune system response in the body going haywire in its response, not damage caused by the virus itself.
Part 2: https://buff.ly/2VuHGTx”
You may have seen this chart in my last newsletter, but it’s believed a bats’ ability to keep their inflammatory response down is one of the reasons they are able to harbor many types of viruses. Most coronavirus-related deaths in humans are due to the immune system response in the body going haywire in its response, not damage caused by the virus itself.
Continue reading “You may have seen this chart in my last newsletter” »
Treating COVID-19 patents with hydroxychloroquine, a derivative of chloroquine generally thought to have less severe side effects, has become standard at many hospitals. The drug is often combined with the antibiotic azithromycin, which some studies suggest also has antiviral effects. The U.S. Food and Drug Administration has authorized emergency use of both chloroquine and hydroxychloroquine for COVID-19 patients. But no large, randomized trial has proved these drugs—alone or in combination with azithromycin—are effective against the disease.
Cardiologists urge careful monitoring of patients on chloroquine or hydroxychloroquine.
A faster way of testing for coronavirus was implemented at Ichilov Hospital in Tel Aviv on Wednesday, which allows for the test results to be retrieved in under 90 minutes, Channel 12reported. “It is an advanced and reliable technology that gives hospitals the opportunity to get the result back from a coronavirus test in fewer than 90 minutes,” Dr. Hanoh Goldschmidt, head of the Laboratory Department in Ichilov Hospital told Channel 12.
The Oxford scientists are extraordinarily confident that their vaccine against the coronavirus will work.
The government’s chief medical officer insists a jab is still 12 to 18 months off and some form of social distancing will be needed until it’s in widespread use.
Their confidence is built on past success. The same vaccine technology has been used on other diseases, including the related coronavirus MERS, as well as Ebola.
Continue reading “Coronavirus: Why Oxford university is so confident in an early vaccine win” »
